Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.67 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.67 |
| ▸ | FAAH2 | Q6GMR7 | 1/20 | 0.67 |
| ▸ | MGLL | Q99685 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4750537 | 0.87 | FAAH (0.86) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL4183181 | 0.83 | FAAH (0.71) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL4965649 | 0.82 | FAAH (0.66) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL4751725 | 0.81 | FAAH (0.65) | FAAHTRPA1EPHX2FAAH2MGLL | |
| Urb-597 SCHEMBL29371698 | 0.81 | FAAH (1.00) | FAAHTRPA1EPHX2FAAH2MGLL | |
| Urb-597 SCHEMBL93842 | 0.81 | FAAH (1.00) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL4748396 | 0.80 | FAAH (0.62) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL14187855 | 0.79 | FAAH (0.98) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL14470485 | 0.79 | FAAH (0.62) | FAAHTRPA1EPHX2FAAH2MGLL | |
| SCHEMBL14288605 | 0.79 | FAAH (0.58) | FAAHTRPA1EPHX2FAAH2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008129129-A1 | HETEROCYCLIC PHENYL CARBAMATES AS NOVEL FAAH-INHIBITORS | KUOPION YLIOPISTO (FI) | 2008-10-30 | — | — | WO | disclosed |